Advertisement

Nancy A. Dawson, MD, on selecting the appropriate I-O + TKI combo in the treatment of 1st line RCC

Nancy A. Dawson, MD, on selecting the appropriate I-O + TKI combo in the treatment of 1st line RCC Dr. Dawson, Professor of Medicine, Lombardi Cancer Center, Georgetown University Hospital, on how to decide between the various combinations of immuno-oncology (I-O) and TKIs available and indicated for the treatment of 1st line renal cell carcinoma (RCC)

line

Post a Comment

0 Comments